StonvexLoading…
StonvexStonvexStonvexCore line items from PGR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $22.19B | $87.67B | $64.92B | $42.41B |
Operating Income | $3.57B | $14.22B | $10.54B | $7.22B |
Net Income | $2.82B | $11.31B | $8.36B | $5.74B |
EPS (Diluted) | $4.80 | $19.23 | $14.21 | $9.77 |
Total Assets | $122.21B | $123.04B | $121.53B | $115.48B |
Total Liabilities | $90.17B | $92.72B | $86.09B | $82.88B |
Cash & Equivalents | $179.00M | $138.00M | $185.00M | $135.00M |
Free Cash Flow OCF − CapEx | $4.30B | $17.20B | $14.15B | $9.02B |
Shares Outstanding | 586.90M | 588.10M | 588.10M | 587.70M |